Day One: Capital Markets & InvestmentTuesday, 30 September 2025

The life science investment ecosystem is undergoing significant recalibration globally, with capital allocation strategies evolving in response to market pressures, scientific breakthroughs, and geopolitical shifts. This panel aims to examine the nuanced global investment landscape across major markets, highlighting divergent regional approaches and emerging opportunities for cross-border capital deployment.

• Analyzing the post-correction investment environment and how capital is being strategically deployed across early-stage innovation, clinical-stage assets, and commercial-ready portfolios
• Examining the evolving dynamics between Western investors and emerging biotech hubs, particularly the bidirectional investment patterns with China's maturing life science sector
• Mapping where global capital is concentrating across modalities, with particular attention to the investment case for advanced therapeutics